ANAVEX LIFE SCIENCES CORP's ticker is AVXL and the CUSIP is 032797300. A total of 58 filers reported holding ANAVEX LIFE SCIENCES CORP in Q1 2018. The put-call ratio across all filers is 4.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $191,385 | -12.2% | 45,352 | +93.8% | 0.00% | – |
| Q4 2023 | $217,882 | -20.9% | 23,403 | -44.4% | 0.00% | -100.0% |
| Q3 2023 | $275,559 | +123.1% | 42,070 | +176.9% | 0.00% | – |
| Q2 2023 | $123,519 | -95.6% | 15,193 | -94.9% | 0.00% | -100.0% |
| Q4 2022 | $2,783,649 | +1244.8% | 300,610 | +1398.0% | 0.01% | +1000.0% |
| Q3 2022 | $207,000 | -8.0% | 20,068 | +54.8% | 0.00% | 0.0% |
| Q4 2021 | $225,000 | -79.4% | 12,967 | -78.7% | 0.00% | -66.7% |
| Q3 2021 | $1,093,000 | +17.7% | 60,868 | +49.9% | 0.00% | -25.0% |
| Q2 2021 | $929,000 | +75.0% | 40,619 | +14.4% | 0.00% | +33.3% |
| Q1 2021 | $531,000 | +107.4% | 35,503 | -36.8% | 0.00% | 0.0% |
| Q3 2020 | $256,000 | +540.0% | 56,155 | +344.6% | 0.00% | – |
| Q3 2019 | $40,000 | -27.3% | 12,631 | -25.9% | 0.00% | -100.0% |
| Q4 2017 | $55,000 | -28.6% | 17,054 | +18.4% | 0.00% | -50.0% |
| Q2 2017 | $77,000 | +87.8% | 14,400 | +28.6% | 0.00% | -33.3% |
| Q3 2016 | $41,000 | -61.7% | 11,200 | -48.9% | 0.00% | -62.5% |
| Q1 2016 | $107,000 | – | 21,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AllSquare Wealth Management LLC | 51,966 | $219,297 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 220,860 | $932 | 0.06% |
| SAXON INTERESTS, INC. | 26,699 | $112,670 | 0.05% |
| Hikari Power Ltd | 85,585 | $361 | 0.03% |
| Sculptor Capital LP | 371,400 | $1,567,308 | 0.03% |
| Sculptor Capital LP | 370,400 | $1,563,088 | 0.03% |
| Y-Intercept (Hong Kong) Ltd | 94,578 | $399,119 | 0.02% |
| Opus Capital Group, LLC | 32,700 | $138 | 0.02% |
| Hayek Kallen Investment Management | 11,863 | $50 | 0.02% |
| Geneos Wealth Management Inc. | 89,725 | $378,640 | 0.02% |